Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

In vivo analysis of human immune responses in immunodeficient rats.

Ménoret S, Ouisse LH, Tesson L, Remy S, Usal C, Guiffes A, Chenouard V, Royer PJ, Evanno G, Vanhove B, Piaggio E, Anegon I.

Transplantation. 2019 Nov 15. doi: 10.1097/TP.0000000000003047. [Epub ahead of print]

PMID:
31764762
2.

Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells.

Fourrier A, Delbos F, Menoret S, Collet C, Thi Thuy LT, Myara A, Petit F, Tolosa L, Laplanche S, Gómez-Lechón MJ, Labrune P, Anegon I, Vallier L, Garnier D, Nguyen TH.

Xenotransplantation. 2019 Jul 25:e12544. doi: 10.1111/xen.12544. [Epub ahead of print]

PMID:
31342573
3.

Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune Disease.

Ossart J, Moreau A, Autrusseau E, Ménoret S, Martin JC, Besnard M, Ouisse LH, Tesson L, Flippe L, Kisand K, Peterson P, Hubert FX, Anegon I, Josien R, Guillonneau C.

J Immunol. 2018 Aug 1;201(3):874-887. doi: 10.4049/jimmunol.1701318. Epub 2018 Jun 29.

4.

Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.

Ménoret S, Ouisse LH, Tesson L, Delbos F, Garnier D, Remy S, Usal C, Concordet JP, Giovannangeli C, Chenouard V, Brusselle L, Merieau E, Nerrière-Daguin V, Duteille F, Bellier-Waast F, Fraichard A, Nguyen TH, Anegon I.

Transplantation. 2018 Aug;102(8):1271-1278. doi: 10.1097/TP.0000000000002251.

PMID:
29688994
5.

CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair.

Charpentier M, Khedher AHY, Menoret S, Brion A, Lamribet K, Dardillac E, Boix C, Perrouault L, Tesson L, Geny S, De Cian A, Itier JM, Anegon I, Lopez B, Giovannangeli C, Concordet JP.

Nat Commun. 2018 Mar 19;9(1):1133. doi: 10.1038/s41467-018-03475-7.

6.

Generation of gene-edited rats by delivery of CRISPR/Cas9 protein and donor DNA into intact zygotes using electroporation.

Remy S, Chenouard V, Tesson L, Usal C, Ménoret S, Brusselle L, Heslan JM, Nguyen TH, Bellien J, Merot J, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Sci Rep. 2017 Nov 29;7(1):16554. doi: 10.1038/s41598-017-16328-y.

7.

Advances in transgenic animal models and techniques.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Anegon I.

Transgenic Res. 2017 Oct;26(5):703-708. doi: 10.1007/s11248-017-0038-x. Epub 2017 Aug 5.

PMID:
28780744
8.

Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats.

Jung CJ, Ménoret S, Brusselle L, Tesson L, Usal C, Chenouard V, Remy S, Ouisse LH, Poirier N, Vanhove B, de Jong PJ, Anegon I.

Sci Rep. 2016 Aug 17;6:31455. doi: 10.1038/srep31455.

9.

A Rapid and Cost-Effective Method for Genotyping Genome-Edited Animals: A Heteroduplex Mobility Assay Using Microfluidic Capillary Electrophoresis.

Chenouard V, Brusselle L, Heslan JM, Remy S, Ménoret S, Usal C, Ouisse LH, NGuyen TH, Anegon I, Tesson L.

J Genet Genomics. 2016 May 20;43(5):341-8. doi: 10.1016/j.jgg.2016.04.005. Epub 2016 May 4.

PMID:
27209567
10.

Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.

Renaud JB, Boix C, Charpentier M, De Cian A, Cochennec J, Duvernois-Berthet E, Perrouault L, Tesson L, Edouard J, Thinard R, Cherifi Y, Menoret S, Fontanière S, de Crozé N, Fraichard A, Sohm F, Anegon I, Concordet JP, Giovannangeli C.

Cell Rep. 2016 Mar 8;14(9):2263-2272. doi: 10.1016/j.celrep.2016.02.018. Epub 2016 Feb 25.

11.

Genome Editing in Rats Using TALE Nucleases.

Tesson L, Remy S, Ménoret S, Usal C, Thinard R, Savignard C, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Methods Mol Biol. 2016;1338:245-59. doi: 10.1007/978-1-4939-2932-0_18.

PMID:
26443226
12.

Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins.

Ménoret S, De Cian A, Tesson L, Remy S, Usal C, Boulé JB, Boix C, Fontanière S, Crénéguy A, Nguyen TH, Brusselle L, Thinard R, Gauguier D, Concordet JP, Cherifi Y, Fraichard A, Giovannangeli C, Anegon I.

Sci Rep. 2015 Oct 7;5:14410. doi: 10.1038/srep14410.

13.

Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Nguyen TH, David L, Anegon I.

Transgenic Res. 2015 Dec;24(6):1079-85. doi: 10.1007/s11248-015-9904-6. Epub 2015 Sep 10. No abstract available.

PMID:
26358113
14.

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Martin JC, Bériou G, Heslan M, Bossard C, Jarry A, Abidi A, Hulin P, Ménoret S, Thinard R, Anegon I, Jacqueline C, Lardeux B, Halary F, Renauld JC, Bourreille A, Josien R.

Mucosal Immunol. 2016 Mar;9(2):539-49. doi: 10.1038/mi.2015.83. Epub 2015 Sep 2.

PMID:
26329427
15.

Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells.

Bézie S, Picarda E, Tesson L, Renaudin K, Durand J, Ménoret S, Mérieau E, Chiffoleau E, Guillonneau C, Caron L, Anegon I.

PLoS One. 2015 Mar 12;10(3):e0119686. doi: 10.1371/journal.pone.0119686. eCollection 2015.

16.

Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases.

Remy S, Tesson L, Menoret S, Usal C, De Cian A, Thepenier V, Thinard R, Baron D, Charpentier M, Renaud JB, Buelow R, Cost GJ, Giovannangeli C, Fraichard A, Concordet JP, Anegon I.

Genome Res. 2014 Aug;24(8):1371-83. doi: 10.1101/gr.171538.113. Epub 2014 Jul 2.

17.

IgG response to intracerebral xenotransplantation: specificity and role in the rejection of porcine neurons.

Mathieux E, Nerrière-Daguin V, Lévèque X, Michel-Monigadon D, Durand T, Bonnamain V, Ménoret S, Anegon I, Naveilhan P, Neveu I.

Am J Transplant. 2014 May;14(5):1109-19. doi: 10.1111/ajt.12656. Epub 2014 Mar 10.

18.

Gene targeting in rats using transcription activator-like effector nucleases.

Ménoret S, Tesson L, Rémy S, Usal C, Thépenier V, Thinard R, Ouisse LH, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Methods. 2014 Aug 15;69(1):102-7. doi: 10.1016/j.ymeth.2014.02.027. Epub 2014 Feb 28.

PMID:
24583114
19.

Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions.

Ma B, Osborn MJ, Avis S, Ouisse LH, Ménoret S, Anegon I, Buelow R, Brüggemann M.

J Immunol Methods. 2013 Dec 31;400-401:78-86. doi: 10.1016/j.jim.2013.10.007. Epub 2013 Oct 30.

20.

Technical advances in the generation of transgenic animals and in their applications. Nantes, France, June 7th 2013.

Ménoret S, Tesson L, Rémy S, Thinard R, Usal C, Ouisse LH, Thepenier V, Anegon I.

Transgenic Res. 2013 Oct;22(5):1065-72. doi: 10.1007/s11248-013-9736-1. Epub 2013 Aug 2. No abstract available.

PMID:
23907705
21.

High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Osborn MJ, Ma B, Avis S, Binnie A, Dilley J, Yang X, Lindquist K, Ménoret S, Iscache AL, Ouisse LH, Rajpal A, Anegon I, Neuberger MS, Buelow R, Brüggemann M.

J Immunol. 2013 Feb 15;190(4):1481-90. doi: 10.4049/jimmunol.1203041. Epub 2013 Jan 9. Erratum in: J Immunol. 2013 Jun 15;190(12):6707.

22.

Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases.

Ménoret S, Fontanière S, Jantz D, Tesson L, Thinard R, Rémy S, Usal C, Ouisse LH, Fraichard A, Anegon I.

FASEB J. 2013 Feb;27(2):703-11. doi: 10.1096/fj.12-219907. Epub 2012 Nov 12.

PMID:
23150522
23.

Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas.

Iscache AL, Ménoret S, Tesson L, Rémy S, Usal C, Pedros C, Saoudi A, Buelow R, Anegon I.

Int Immunol. 2011 Oct;23(10):625-36. doi: 10.1093/intimm/dxr071. Epub 2011 Sep 19.

PMID:
21930595
24.

Knockout rats generated by embryo microinjection of TALENs.

Tesson L, Usal C, Ménoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L, Gregory PD, Anegon I, Cost GJ.

Nat Biotechnol. 2011 Aug 5;29(8):695-6. doi: 10.1038/nbt.1940. No abstract available.

PMID:
21822240
25.

Characterization of immunoglobulin heavy chain knockout rats.

Ménoret S, Iscache AL, Tesson L, Rémy S, Usal C, Osborn MJ, Cost GJ, Brüggemann M, Buelow R, Anegon I.

Eur J Immunol. 2010 Oct;40(10):2932-41. doi: 10.1002/eji.201040939.

26.

Phenotypic and functional characterization of CD8(+) T regulatory cells.

Ménoret S, Guillonneau C, Bezié S, Caron L, Anegon I, Li XL.

Methods Mol Biol. 2011;677:63-83. doi: 10.1007/978-1-60761-869-0_5.

PMID:
20941603
27.

Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.

Li XL, Ménoret S, Bezie S, Caron L, Chabannes D, Hill M, Halary F, Angin M, Heslan M, Usal C, Liang L, Guillonneau C, Le Mauff B, Cuturi MC, Josien R, Anegon I.

J Immunol. 2010 Jul 15;185(2):823-33. doi: 10.4049/jimmunol.1000120. Epub 2010 Jun 11.

28.

New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Remy S, Tesson L, Usal C, Menoret S, Bonnamain V, Nerriere-Daguin V, Rossignol J, Boyer C, Nguyen TH, Naveilhan P, Lescaudron L, Anegon I.

Transgenic Res. 2010 Oct;19(5):745-63. doi: 10.1007/s11248-009-9352-2. Epub 2010 Jan 22.

PMID:
20094912
29.

Analysis by quantitative PCR of zygosity in genetically modified organisms.

Tesson L, Rémy S, Ménoret S, Usal C, Anegon I.

Methods Mol Biol. 2010;597:277-85. doi: 10.1007/978-1-60327-389-3_19.

PMID:
20013240
30.

Generation of gene-specific mutated rats using zinc-finger nucleases.

Geurts AM, Cost GJ, Rémy S, Cui X, Tesson L, Usal C, Ménoret S, Jacob HJ, Anegon I, Buelow R.

Methods Mol Biol. 2010;597:211-25. doi: 10.1007/978-1-60327-389-3_15.

PMID:
20013236
31.

The use of lentiviral vectors to obtain transgenic rats.

Remy S, Nguyen TH, Ménoret S, Tesson L, Usal C, Anegon I.

Methods Mol Biol. 2010;597:109-25. doi: 10.1007/978-1-60327-389-3_8.

PMID:
20013229
32.

Generation of transgenic rats by microinjection of short DNA fragments.

Ménoret S, Remy S, Usal C, Tesson L, Anegon I.

Methods Mol Biol. 2010;597:81-92. doi: 10.1007/978-1-60327-389-3_6.

PMID:
20013227
33.

"Transgenesis, recent technical developments and applications" Nantes, 8th June 2009.

Ménoret S, Tesson L, Remy S, Usal C, Iscache AL, Anegon I.

Transgenic Res. 2010 Aug;19(4):711-4. doi: 10.1007/s11248-009-9340-6. Epub 2009 Nov 1. No abstract available.

PMID:
19882223
34.

Zinc-finger nucleases: a powerful tool for genetic engineering of animals.

Rémy S, Tesson L, Ménoret S, Usal C, Scharenberg AM, Anegon I.

Transgenic Res. 2010 Jun;19(3):363-71. doi: 10.1007/s11248-009-9323-7. Epub 2009 Sep 26. Review.

PMID:
19821047
35.

Knockout rats via embryo microinjection of zinc-finger nucleases.

Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, Vincent A, Lam S, Michalkiewicz M, Schilling R, Foeckler J, Kalloway S, Weiler H, Ménoret S, Anegon I, Davis GD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jacob HJ, Buelow R.

Science. 2009 Jul 24;325(5939):433. doi: 10.1126/science.1172447.

36.

Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.

Li XL, Ménoret S, Le Mauff B, Angin M, Anegon I.

Transplantation. 2008 Jul 15;86(1):10-5. doi: 10.1097/TP.0b013e31817c4b97. Review.

PMID:
18622269
37.

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Hervé C, Li XL, Heslan M, Usal C, Tesson L, Ménoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I.

J Clin Invest. 2007 Apr;117(4):1096-106.

38.

Transgenic modifications of the rat genome.

Tesson L, Cozzi J, Ménoret S, Rémy S, Usal C, Fraichard A, Anegon I.

Transgenic Res. 2005 Oct;14(5):531-46. Review.

PMID:
16245144
39.

PTB regulates the processing of a 3'-terminal exon by repressing both splicing and polyadenylation.

Le Sommer C, Lesimple M, Mereau A, Menoret S, Allo MR, Hardy S.

Mol Cell Biol. 2005 Nov;25(21):9595-607.

40.

[Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta3-adrenoceptors].

Toumaniantz G, Seze C, Serpillon S, Menoret S, Tesson L, Anégone I, Gauthier C.

Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):836-40. French.

PMID:
16220757
41.

Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination.

Ménoret S, Plat M, Blancho G, Martinat-Botté F, Bernard P, Karam G, Tesson L, Renaudin K, Guillouet P, Weill B, Chéreau C, Houdebine LM, Soulillou JP, Terqui M, Anegon I.

Transplantation. 2004 May 15;77(9):1468-71.

PMID:
15167611
42.

Immunobiological characterization of N -nitrosomethylurea-induced rat breast carcinomas: tumoral IL-10 expression as a possible immune escape mechanism.

Hill M, Bausero M, Mazal D, Ménoret S, Khalife J, Anegón I, Osinaga E.

Breast Cancer Res Treat. 2004 Mar;84(2):107-16.

PMID:
14999141
43.

Generation of heme oxygenase-1-transgenic rats.

Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Buelow R, Anegon I, Chauveau C.

Exp Biol Med (Maywood). 2003 May;228(5):466-71.

PMID:
12709570
44.

Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.

Guillot C, Ménoret S, Guillonneau C, Braudeau C, Castro MG, Lowenstein P, Anegon I.

Blood. 2003 Apr 15;101(8):3325-33. Epub 2002 Dec 19.

PMID:
12515725
45.

No functional benefit for hDAF-transgenic rat livers despite protection from tissue damage following perfusion with human serum.

Stockmann H, Verbakel C, Okkema P, Bonthuis F, Menoret S, Anegon I, Marquet R, IJzermans J.

Transpl Int. 2002 Dec;15(12):595-601. Epub 2002 Oct 19.

PMID:
12478405
46.

Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels.

Bouchet D, Tesson L, Ménoret S, Charreau B, Mathieu P, Yagita H, Duisit G, Anegon I.

Mol Med. 2002 Oct;8(10):612-23.

47.

A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles.

Pitard B, Pollard H, Agbulut O, Lambert O, Vilquin JT, Cherel Y, Abadie J, Samuel JL, Rigaud JL, Menoret S, Anegon I, Escande D.

Hum Gene Ther. 2002 Sep 20;13(14):1767-75.

PMID:
12396628
48.

lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

Ménoret S, Aubert D, Tesson L, Braudeau C, Pichard V, Ferry N, Anegon I.

Hum Gene Ther. 2002 Jul 20;13(11):1383-90.

PMID:
12162820
49.

Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat.

Aubert D, Ménoret S, Chiari E, Pichard V, Durand S, Tesson L, Moullier P, Anegon I, Ferry N.

Mol Ther. 2002 Apr;5(4):388-96.

50.

Rapid and accurate determination of zygosity in transgenic animals by real-time quantitative PCR.

Tesson L, Heslan JM, Ménoret S, Anegon I.

Transgenic Res. 2002 Feb;11(1):43-8.

PMID:
11874102

Supplemental Content

Loading ...
Support Center